Education
About Us
Working with TipRanks
Follow Us
Stevanato Group (STVN)
NYSE:STVN
Earnings Data
Report Date
Aug 14, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.12Last Year’s EPS
0.09Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 10.18%
|Next Earnings Date:Aug 14, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive start to fiscal 2025 with robust revenue growth and operational improvements in the BDS segment. However, challenges remain in the Engineering segment and due to tariff impacts. The positive aspects slightly outweigh the negatives, indicating a cautiously optimistic outlook for the year.Company Guidance
In the Stevanato Group's first quarter 2025 results call, the company reported a 9% revenue growth, reaching EUR 256.6 million, driven by an 11% increase in the Biopharmaceutical and Diagnostics Solutions (BDS) segment, which offset a 4% decline in the Engineering segment. High-value solutions, including a partial recovery in EZ-fill vials, accounted for 43% of total revenue, growing 25% year-over-year to EUR 110.3 million. The company's gross profit margin increased by 80 basis points to 27.2%, while the operating profit margin rose by 280 basis points to 13.5%. Adjusted EBITDA was EUR 57.4 million, with a margin improvement of 100 basis points to 22.4%. The company also updated its full-year guidance, expecting revenue between EUR 1.160 billion and EUR 1.190 billion and adjusted EBITDA between EUR 288.5 million and EUR 301.8 million, factoring in an anticipated EUR 4.5 million impact from tariffs.Strong Revenue Growth
The company reported a 9% increase in revenue in the first quarter of 2025, driven by a strong performance in the Biopharmaceutical and Diagnostics Solutions Segment.
High-Value Solutions Growth
Revenue from high-value solutions grew 25% in the first quarter to EUR 110.3 million, accounting for 43% of total revenue.
Operational Improvements in BDS Segment
The BDS segment saw an 11% growth in revenue, supported by improvements at Latina and Fishers facilities.
Margin Expansion
Consolidated gross profit margin increased by 80 basis points to 27.2%, while operating profit margin increased by 280 basis points to 13.5%.
Order Intake Growth
Double-digit growth in order intake for both bulk and sterile vials compared to the previous year.
---
STVN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STVN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $21.80 | $22.48 | +3.12% |
Mar 06, 2025 | $19.06 | $20.70 | +8.60% |
Nov 05, 2024 | $19.38 | $22.50 | +16.10% |
Aug 06, 2024 | $18.79 | $19.87 | +5.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Stevanato Group (STVN) report earnings?
Stevanato Group (STVN) is schdueled to report earning on Aug 14, 2025, TBA Not Confirmed.
What is Stevanato Group (STVN) earnings time?
Stevanato Group (STVN) earnings time is at Aug 14, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STVN EPS forecast?
STVN EPS forecast for the fiscal quarter 2025 (Q2) is 0.12.
---